Summary of Product Characteristics
last updated on the eMC:
09/06/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 09/06/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and method of administration
-
Change to section 4.4 - Special warnings and precautions for Use
|
| Date of revision of text on the SPC: 06-Jun-2011 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Variation to update sections 4.2 (Posology and administration) and 4.4 (Special warnings) to include paediatric posology requested by MHRA with regards to paracetamol containing products.
|
|
Updated on 26/10/2009 and displayed until 09/06/2011
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
-
Change to section 4.8 - Undesirable Effects
|
| Date of revision of text on the SPC: 05-Oct-2009 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Update to sections
4.1 of the SPC to include the indications of colds and influenza and to harmonise the other indications throughout the range.
4.8 of the SPC to add ‘anaphylactic reactions’ as a possible side-effect
Other updates to several sections of the SPC in line with current QRD template/regulatory guidelines and rephrasing of the storage conditions to some licences to align with the wording used across the current Calpol 6+ product range.
|
|
Updated on 08/05/2009 and displayed until 26/10/2009
|
Reasons for adding or updating:
|
-
Change to section 9 - Date of first Authorisation/renewal of the Authorisation
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 11-Mar-2009 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Renewal of product licence – SPC has been updated to reflect this renewal date and date of revision.
|
|
Updated on 24/04/2008 and displayed until 08/05/2009
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
| Date of revision of text on the SPC: 04/2008 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change to MA as a result of integration
|
|
Updated on 08/08/2007 and displayed until 24/04/2008
|
Reasons for adding or updating:
|
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 07/2005 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 10: Change to the revision of the text
|
|
Updated on 25/09/2006 and displayed until 08/08/2007
|
Reasons for adding or updating:
|
-
Addition of separate SPCs covering individual presentations
|
| Date of revision of text on the SPC: 07/2005 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| The original SPC for six plus fast melts has been seperated into two due to different packsizes and legal catagories
|
|